Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
GlaxoSmithKline plc
Index- P/E14.12 EPS (ttm)3.72 Insider Own- Shs Outstand2.45B Perf Week-0.08%
Market Cap128.41B Forward P/E12.90 EPS next Y4.07 Insider Trans- Shs Float2.43B Perf Month-4.02%
Income9.10B PEG1.52 EPS next Q- Inst Own10.50% Short Float0.26% Perf Quarter-0.87%
Sales44.35B P/S2.90 EPS this Y22.70% Inst Trans-0.03% Short Ratio2.56 Perf Half Y7.08%
Book/sh4.85 P/B10.83 EPS next Y9.26% ROA17.70% Target Price61.13 Perf Year9.19%
Cash/sh3.81 P/C13.79 EPS next 5Y9.30% ROE114.20% 52W Range46.60 - 56.60 Perf YTD-0.32%
Dividend3.00 P/FCF41.93 EPS past 5Y4.70% ROI24.90% 52W High-7.23% Beta0.63
Dividend %5.71% Quick Ratio0.80 Sales past 5Y1.70% Gross Margin69.80% 52W Low12.69% ATR0.72
Employees99451 Current Ratio1.10 Sales Q/Q1.50% Oper. Margin28.20% RSI (14)43.91 Volatility0.97% 1.10%
OptionableYes Debt/Eq2.61 EPS Q/Q194.70% Profit Margin27.90% Rel Volume0.90 Prev Close52.82
ShortableYes LT Debt/Eq2.21 EarningsFeb 03 Payout68.70% Avg Volume2.45M Price52.51
Recom2.60 SMA20-0.78% SMA50-2.93% SMA2001.82% Volume2,211,719 Change-0.59%
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
25-May-07Reiterated Banc of America Sec Neutral $62 → $57
22-May-07Downgrade Deutsche Securities Buy → Hold
17-Apr-14 06:40PM  Potential New Treatment for Alcoholism: Ezogabine at Forbes
05:35PM  Glaxo Looking into Misconduct Charges Zacks
05:24PM  GSK and Genmab receive FDA approval for Arzerra┬« (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate PR Newswire
01:04PM  GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD CNW Group
04:06AM  3 Reasons Why GlaxoSmithKline plc Is More Than Just A Great Income Stock at Motley Fool
12:42AM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
16-Apr-14 10:47PM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
08:40PM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
07:09PM  New Glaxo bribery inquiries Investor's Business Daily
06:48PM  Is Johnson & Johnson's Dividend Unbeatable? at Motley Fool
05:35PM  Glaxo's Tanzeum Approved in the U.S. Zacks
03:10PM  Dynavax Starts Phase III Study on Heplisav-B Zacks
02:28PM  Will Recent News Hurt GlaxoSmithKline? at Wall St. Cheat Sheet
01:38PM  Dear Jenny McCarthy, Here's How Many Lives Could Be Saved Cheaply By Making Vaccines More Widely Available at Forbes
01:32PM  [$$] Glaxo Examines Bribery Claims at The Wall Street Journal
12:26PM  GlaxoSmithKline discloses new bribery inquiries AP
12:25PM  GlaxoSmithKline discloses new bribery inquiries AP
10:46AM  [$$] Glaxo Examines Bribery Claims in Jordan, Lebanon at The Wall Street Journal
10:32AM  [$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon at The Wall Street Journal
05:55AM  (Video) GlaxoSmithKline plc's Bribery Allegations at Motley Fool
15-Apr-14 03:43PM  Will The FDA's Approval Of Type 2 Diabetes Drug Tanzeum Help GlaxoSmithKline (GSK) Stock? at TheStreet
02:26PM  GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum (albiglutide) PR Newswire
12:34PM  Midday movers: Twitter, Aaron's, Herbalife at CNBC
10:14AM  FDA approves Tanzeum to treat type 2 diabetes theflyonthewall.com
09:44AM  The Supreme Court Will Decide the Fate of a Blockbuster at Motley Fool
08:41AM  You Can't Go Far Wrong Buying GlaxoSmithKline plc At Today's Price at Motley Fool
14-Apr-14 04:25PM  GlaxoSmithKlines Collection of Bribery Allegations Multiplies at Wall St. Cheat Sheet
09:53AM  [video] Stocks Open Higher on Citi Surprise, Surging Retail Sales at TheStreet
09:40AM  Europe shares turn higher after US data; Ukraine concerns persist at CNBC
09:40AM  Europe shares flat after US data; Ukraine concerns persist at CNBC
08:51AM  Europe shares turn higher after US data; Ukraine concerns persist at CNBC
07:44AM  Tech selloff hits Europe; Ukraine concerns persist at CNBC
06:00AM  Tech selloff hits Europe; Ukraine concerns persist at CNBC
05:32AM  Glaxo Disciplines Employee After Polish Bribery Charges at Bloomberg
04:53AM  Tech selloff hits Europe; Ukraine concerns persist at CNBC
03:43AM  Tech selloff hits Europe; Ukraine concerns persist at CNBC
11-Apr-14 09:49AM  AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore at Seeking Alpha
04:53AM  Should You Buy GlaxoSmithKline plc After Recent Declines? at Motley Fool
10-Apr-14 11:42AM  Report claims Tamiflu, Relenza do little to prevent the spread of flu at theflyonthewall.com
10:02AM  [video] Celgene CEO: Intellectual property is lifeblood of innovation at CNBC
08:21AM  [video] Alkermes is a true drug innovator: CEO at CNBC
06:51AM  [video] Eli Lilly CEO: We keep investing in R&D at CNBC
06:27AM  Governments 'wasted millions on flu drugs': Report at CNBC
09-Apr-14 03:45PM  Teva to Launch Generic Lovaza Zacks
08:40AM  Tale Of Two Heart Drugs Show Challenges And Rewards In R&D at Forbes
08-Apr-14 12:28PM  Study Suggests Link Between Viagra And Melanoma at Forbes
10:47AM  Teva launches generic version of fish oil drug AP
10:13AM  Can GlaxoSmithKline Recover? at Wall St. Cheat Sheet
09:01AM  GlaxoSmithKline plc Tops The Pharmaceuticals sector at Motley Fool
07-Apr-14 06:46PM  GlaxoSmithKline Investor's Business Daily
03:31PM  GlaxoSmithKline Faces Bribery Allegations Yet Again, This Time in Iraq at Wall St. Cheat Sheet
02:04PM  GlaxoSmithKline launches probe into claims of misconduct in Iraq at Los Angeles Times
09:21AM  [$$] Glaxo Investigates Bribery Accusations in the Mideast at The Wall Street Journal
07:44AM  Story Stocks from Briefing.com Briefing.com
07:23AM  Story Stocks from Briefing.com Briefing.com
04:52AM  Glaxo Investigates Alleged Improper Conduct in Iraq at Bloomberg
03:31AM  [$$] Glaxo Investigates Bribery Accusations in the Mideast at The Wall Street Journal
01:24AM  [$$] Glaxo Investigates Bribery Accusations in the Mideast at The Wall Street Journal
12:45AM  [$$] Glaxo Investigates Bribery Accusations in the Mideast at The Wall Street Journal
06-Apr-14 09:28PM  Glaxo Starts Investigating Possible Iraq Misconduct at New York Times
04:23PM  GlaxoSmithKline investigates bribery allegations in Iraq, WSJ says at theflyonthewall.com
04-Apr-14 03:45PM  Glaxo and Amgen Terminate Agreement Zacks
09:00AM  Story Stocks from Briefing.com Briefing.com
08:25AM  Theravance Is A Classic Ben Graham Bargain at Seeking Alpha
07:48AM  [$$] GlaxoSmithKline Cuts China Staff at The Wall Street Journal
04:50AM  [$$] GlaxoSmithKline Cuts China Staff at The Wall Street Journal
03-Apr-14 05:15PM  Glaxo Stops MAGE-A3 Lung Cancer Study Zacks
11:12AM  Amgen, GSK End Marketing Partnership for Osteoporosis Drug at Fox Business
08:57AM  Story Stocks from Briefing.com Briefing.com
07:28AM  Story Stocks from Briefing.com Briefing.com
06:08AM  GlaxoSmithKline plc Bets Big On Africa at Motley Fool
02-Apr-14 05:17PM  Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic? at Motley Fool
10:42AM  GlaxoSmithKline plc Stumbles But It's Still A Buy at Motley Fool
07:47AM  Story Stocks from Briefing.com Briefing.com
07:44AM  Agenus down 9.4% after GlaxoSmithKline stops MAGRITi Phase 3 trial at theflyonthewall.com
07:40AM  Early movers: GM, WFC, TWC, CHTR, GSK, AMZN & more at CNBC
06:00AM  Europe Moves to Make Drug Trial Data More Transparent at BusinessWeek
04:53AM  Is There Still Time To Buy GlaxoSmithKline plc? at Motley Fool
01-Apr-14 05:31PM  Biotech Auxilium Boosts Position In Men's Health Care at Investor's Business Daily
02:30PM  ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool PR Newswire
12:15PM  Midday movers: Wynn, MGM, Darden & more at CNBC
07:13AM  GlaxoSmithKline investing to expand in Africa, Independent says at theflyonthewall.com
03:55AM  Buy Stocks Like Diageo plc And GlaxoSmithKline plc To Hedge Against Labour Victory at Motley Fool
31-Mar-14 07:13PM  Can Arena and VIVUS Profit From Glaxo's Troubles? at Motley Fool
05:30PM  Glaxo Presents Darapladib Data Zacks
03:21PM  Why GlaxoSmithKline PLC Shrugged Off Alli's Recall at Motley Fool
02:48PM  Theravance: Baby Thrown Out With The Bath Water - 35% To 65% Upside at Seeking Alpha
11:20AM  Glaxo's Utter Stinkbomb Of A Drug at Forbes
08:43AM  [$$] Novartis Boosted by Heart Drug Trials at The Wall Street Journal
08:09AM  [$$] Johnson & Johnson Accepts Bid for Blood-Testing Unit at The Wall Street Journal
30-Mar-14 08:01PM  3 Dividend Stocks for Next Quarter at Motley Fool
03:31PM  2 Obamacare Prescription Drug Assistance Programs Ending: What You Need to Know at Motley Fool
28-Mar-14 06:31PM  3 Reasons to Buy Novavax, Inc. at Motley Fool
02:15PM  Fat-blocking diet pill recalled after tampering reports at USA TODAY
01:31PM  Update on Glaxo's Mekinist-Tafinlar Zacks
12:02PM  Fat-blocking diet pill recalled after tampering reports at USA TODAY
11:28AM  Fat-blocking diet pill recalled after tampering reports at USA TODAY
10:59AM  Fat-blocking diet pill recalled after tampering reports at USA TODAY
10:30AM  Fat-blocking diet pill recalled after tampering reports at USA TODAY
10:05AM  Fat-blocking diet pill recalled after tampering reports at USA TODAY
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM
GLAXOSMITHKLINE PLC10% OwnerOct 29Buy4913613.18130,473641,093,852,43429,916,073Oct 29 05:37 PM
GLAXOSMITHKLINE PLC10% OwnerJul 30Buy111850855.503,064,407342,756,544,550,18929,785,600Aug 01 09:23 AM
GLAXOSMITHKLINE PLC10% OwnerApr 30Buy6699215.43193,5631,296,720,236,27726,721,193Apr 30 02:38 PM